Co-epidemics: have measures against COVID-19 helped to reduce Lassa fever cases in Nigeria?

R C Reuben1, S D Gyar2, M D Makut2

  • 1German Centre for Integrative Biodiversity Research (iDiv), Halle-Jena-Leipzig, Germany.

Insights

The COVID-19 pandemic unexpectedly reduced Lassa fever cases in Nigeria due to implemented infection control measures. Further research is needed to understand the interaction between these two epidemics.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Nigeria faces concurrent epidemics of COVID-19 and Lassa fever.
  • Clinical similarities between COVID-19 and Lassa fever pose diagnostic challenges and risk of co-infection.
  • The Lassa fever epidemic is recurrent in West Africa.

Purpose of the Study:

  • To investigate the impact of COVID-19 infection prevention and control (IPC) measures on Lassa fever epidemiology in Nigeria.
  • To understand the interaction and evolutionary dynamics between Lassa fever and COVID-19.
  • To analyze the abrupt changes in Lassa fever data during the COVID-19 pandemic.

Main Methods:

  • Observational study analyzing epidemiological data of Lassa fever.
  • Comparison of Lassa fever case numbers before and after the implementation of COVID-19 IPC measures.
  • Assessment of national, sub-national, and community-level IPC strategies.

Main Results:

  • Implementation of COVID-19 IPC measures led to a concurrent reduction in Lassa fever cases across Nigeria.
  • The strict adherence to infection control protocols for COVID-19 influenced Lassa fever transmission dynamics.
  • Significant changes in Lassa fever epidemiological patterns were observed.

Conclusions:

  • COVID-19 IPC measures had an unintended positive effect on controlling Lassa fever transmission in Nigeria.
  • Further investigation is crucial to fully elucidate the interplay between these two diseases and the long-term effects.
  • Understanding these interactions is vital for future public health strategies in West Africa.